Hvis respons forsvandt under vedligeholdelsesbehandlingen var cross- over til en højere dosis (10 mg/ kg) og/ eller kortere doseringsinterval (hver 8. uge) tilladt.
If response was lost during maintenance treatment, crossing over to a higher dose (10 mg/ kg) and/ or shorter dosing interval (q8 weeks) was allowed.